NEW YORK (GenomeWeb) – Investment firm BTIG today upgraded Agilent Technologies' stock to a Buy rating on improving confidence in the company's outlook. 

Analyst Dane Leone upgraded Agilent from an earlier Neutral rating and set the 12-month price target on the firm's stock at $52. In a research note, he cited Agilent's China business, and said that after two years of having to deal issues in the region those operations are poised to improve.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.